E
Enrico Bollito
Researcher at University of Turin
Publications - 94
Citations - 3406
Enrico Bollito is an academic researcher from University of Turin. The author has contributed to research in topics: Prostate cancer & Prostate. The author has an hindex of 29, co-authored 92 publications receiving 2962 citations.
Papers
More filters
Journal ArticleDOI
Adjuvant mitotane treatment for adrenocortical carcinoma.
Massimo Terzolo,Alberto Angeli,Martin Fassnacht,Fulvia Daffara,Libuse Tauchmanovà,Pier Antonio Conton,R. Rossetto,Lisa Buci,Paola Sperone,Erika Grossrubatscher,Giuseppe Reimondo,Enrico Bollito,Mauro Papotti,Wolfgang Saeger,Stefanie Hahner,Ann Cathrin Koschker,Emanuela Arvat,Bruno Ambrosi,Paola Loli,Gaetano Lombardi,Massimo Mannelli,Paolo Bruzzi,Franco Mantero,Bruno Allolio,Luigi Dogliotti,Alfredo Berruti +25 more
TL;DR: Adjuvant mitotane treatment had a significant advantage for recurrence-free survival in patients with radically resected adrenocortical carcinoma, and temporary dose reduction was needed in 13% of patients.
Journal ArticleDOI
Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer
Francesco Porpiglia,Matteo Manfredi,Fabrizio Mele,Marco Cossu,Enrico Bollito,Andrea Veltri,Stefano Cirillo,Daniele Regge,Riccardo Faletti,Roberto Passera,Cristian Fiori,Stefano De Luca +11 more
TL;DR: A diagnostic pathway based on mpMRI had a higher DR than the standard pathway in both PCa and csPCa and the mpMRI-based pathway had better performance than thestandard pathway.
Journal ArticleDOI
Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer
Francesco Porpiglia,Cristian Fiori,Fulvia Daffara,Barbara Zaggia,Enrico Bollito,Marco Volante,Alfredo Berruti,Massimo Terzolo +7 more
TL;DR: There is interesting evidence that OA and LA may be comparable in terms of recurrence-free survival for patients with stage I and II ACC when the principles of surgical oncology are respected.
Journal ArticleDOI
Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential.
Sueli Suzigan,Antonio Lopez-Beltran,Rodolfo Montironi,Ricardo Drut,Ana Romero,Tomayoshi Hayashi,Ana L.C. Gentili,Paulo S.P. Fonseca,Ines deTorres,Athanase Billis,Lucia C. Japp,Enrico Bollito,Ferran Algaba,Maria J. Requena-Tapias +13 more
TL;DR: All 45 patients were alive with no evidence of disease at mean follow-up of 66.1 months, confirming an extremely good prognosis after surgery and a 5-year disease-specific survival rate of 100%.
Journal ArticleDOI
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease
Alfredo Berruti,Alessandra Mosca,Marcello Tucci,Carlo Terrone,Mirella Torta,Roberto Tarabuzzi,Lucianna Russo,Cecilia Maria Cracco,Enrico Bollito,Roberto Mario Scarpa,Alberto Angeli,Luigi Dogliotti +11 more
TL;DR: Elevated plasma CgA levels are frequently observed in prostate cancer patients with hormone-refractory disease and correlate with poor prognosis, and their prognostic role was evaluated together with patient performance status, Gleason score and the presence of visceral metastases.